COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-invasive Measurement of Hemoglobin in Retinal Arteries

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01025011
Recruitment Status : Unknown
Verified November 2009 by Triemli Hospital.
Recruitment status was:  Recruiting
First Posted : December 3, 2009
Last Update Posted : December 3, 2009
Sponsor:
Information provided by:
Triemli Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries.

Condition or disease Intervention/treatment
Healthy Subjects Anemia Device: Fundus photography, cubital blood draw

Detailed Description:

To our knowledge no tool exists that allows for direct collection of hemoglobin data in the eye. In many eye diseases (especially diabetic and hypertensive retinopathy as well as in retinal vessel occlusions) retinal circulation is modified. Knowing hemoglobin concentration on the site of the pathology will give us further information about the pathogenesis of this diseases and may provide a new possibility in therapy.

The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries. Healthy volunteers from the eye clinic and pregnant otherwise healthy patients of the gynecological department of the Triemli Hospital, Zurich, as well as anemic gynecological patients that show up for a check-up are included.

Hemoglobin will be quantified by a blood draw of a cubital vein. Using a Fundus Camera (Nidek AFC-230) pictures of the fundus will be taken from each study patient. Afterwards the study investigator selects a retinal artery of interest which will be used for measuring the hemoglobin concentration. Intensity of the green channel of the camera chip is determined with the aid of the law of Lambert-Beer.

Absolute Hemoglobin concentration is calculated in relation to the vessel volume.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Official Title: Non- Invasive Measurement of the Absolute Hemoglobin Value in the Retinal Arteries of Anemic and Healthy Subjects Using a New Approach
Study Start Date : March 2008
Estimated Primary Completion Date : June 2010
Estimated Study Completion Date : June 2010
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
healthy volunteers, anemic patients
healthy volunteers from the eye and gynecology department pregnant patients with anemia
 Device: Fundus photography, cubital blood draw
blood draw from a cubital vein to measure hemoglobin concentration taking a fundus photography with a Nidek AFC-230, no pupil dilation needed


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Correlation of hemoglobin concentration measured in a cubital vein and in a non invasive way using hemoglobinometry in the retinal veins [ Time Frame: 2.5 years ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy subjects from the eye clinic of Triemli Hospital anemic and pregnant patients from the gynecology department, Triemli Hospital
Criteria

Inclusion Criteria:

  • healthy volunteers
  • pregnant patients from the Triemli Hospital that came for a routine check up
  • anemic patients of the same dept with various gynecological tumors

Exclusion Criteria:

  • any known retinal eye disease
  • poor fundus picture quality due to fixtion problems or too small pupil or media intransparency
  • not willing to participate in a study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01025011


Contacts
Layout table for location contacts
Contact: Yves Robert, Prof MD +41 44 466 ext 3200 yves.robert@triemli.stzh.ch

Locations
Layout table for location information
Switzerland
Stadtpital Zürich, Triemli Hospital Recruiting
Zürich, Switzerland, 8063
Contact: Yves Robert, Prof MD    +41 44 466 ext 3200    yves.robert@triemli.stzh.ch   
Sponsors and Collaborators
Triemli Hospital
Investigators
Layout table for investigator information
Principal Investigator: Yves Robert, Prof MD Triemli Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Prof Yves Robert, Stadtpital Triemli (Triemli Hospital)
ClinicalTrials.gov Identifier: NCT01025011    
Other Study ID Numbers: D20028132
First Posted: December 3, 2009    Key Record Dates
Last Update Posted: December 3, 2009
Last Verified: November 2009
Keywords provided by Triemli Hospital:
retinal hemoglobin concentration
non-invasive hemoglobin measurement